This symposium includes presentations on the contribution of gastric inhibitory peptide and glucagon in dual and triple agonism, the role for amylin in monotherapy and combination therapy, the contribution of PYY in combination treatment with GLP-1, and clinical implications of nutrient-stimulated hormone pharmacotherapy. Watch a livestream or catch the recording on the virtual platform at ADA2023.org.